Exposure to Maternal Pre‐ and Postnatal Psychological Distress: Associations With Brain Structure in 5‐Year‐Old Children
Human Brain Mapping · 2026-11 · 47 (16)
DOI: 10.1002/hbm.70683 ↗Abstract
ABSTRACT Maternal mental health is an important contributor to child neurodevelopment. While there are multiple studies on prenatal exposure, early postnatal exposure has received little attention in neuroimaging research. Five‐year‐old children ( n = 161) were recruited from the FinnBrain Birth Cohort study. Maternal distress was assessed using questionnaires on depressive and anxiety symptoms at 14, 24, and 34 gestational weeks and postnatally at 3, 6, and 24 months. T1‐weighted structural images were processed using a voxel‐based morphometry pipeline to map associations between maternal distress exposure and regional gray matter (GM) volumes. Whole‐brain voxel‐wise general linear models were used, accounting for potential confounders. Additionally, a latent class mixed model approach was used to model longitudinal trajectories of distress exposure. We found widespread associations between maternal postpartum distress symptoms and offspring brain morphology. Postnatal distress at 3 months was negatively associated with GM volumes in the left supplementary motor cortex, right cerebellum/fusiform gyrus, and left anterior insula/frontal operculum. Postnatal distress at 6 months was positively associated with GM volumes in the right cuneus and lingual gyrus, right insula/operculum, and right inferior occipital gyrus, while distress at 24 months was negatively associated with GM volumes in the left inferior/middle frontal gyrus. There were no structural brain differences between the latent classes. This study provides support for hypotheses proposing that early‐life exposure to maternal distress can influence the structural development of the brain. It highlights the role of the early postnatal period and calls for further research into this so far overlooked period and the developmental pathways that explain these associations.
EUVIMED